口服万科米辛用于原发性硬化胆管炎和相关的炎症性肠道疾病 - - 铺平了前进的道路
John Grady1, Kevin M Johnson2, Richard Kellermayer3,4
1Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University, Richmond, VA , USA.
Expert review of gastroenterology & hepatology
|February 20, 2026
概括
口服万科米辛 (OV) 在患有原发性硬化性胆道炎 (PSC) 的患者中显示出治疗炎症性肠病 (IBD) 的前景. 虽然对大肠炎有效,但肝脏反应有所不同,这表明可能需要更高的OV剂量.
科学领域:
- 胃肠病学 胃肠病学
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 初级硬化性胆道炎 (PSC) 是一种慢性肝病,通常与炎症性肠病 (IBD) 相关.
- 目前,没有批准的PSC治疗方法,这造成了治疗挑战.
- 口服万科米辛 (OV) 正在作为一种潜在的治疗选择进行研究.
研究的目的:
- 对治疗原发性硬化性脑膜炎 (PSC) 的口服万科米辛 (OV) 的临床有效性和机制学数据进行审查.
- 综合证据对OV对IBD和PSC-IBD的肝病成分的影响.
主要方法:
- 在PubMed和谷歌学者进行了系统的文献搜索,从1998年到2025年11月,对PSC中的万科米辛进行了研究.
- 数据综合包括临床结果,内镜缓解率,炎症标志物,肝功能测试和成像/组织学发现.
主要成果:
- OV对IBD显示出一致的益处,在儿科和成人PSC-IBD队列中,临床和内镜缓解率高.
- 肝脏对OV的反应是可变的,一些研究显示肝酶显著减少,成像效果有所改善.
- 没有报告出现抗万科米辛的肠球菌的发展.
结论:
- 口服万科米辛 (OV) 在患有PSC-IBD的患者中有效治疗结肠炎.
- 肝脏结果的变化可能与OV剂量,治疗持续时间和选择的终点差异有关.
- 需要进一步的研究,包括跨专业指导和综合试验,以优化在PSC中的OV使用.
更多相关视频
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
832
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
832
Chronic Bowel Disorders: Introduction
829
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
829
Inflammatory Bowel Disease V: Surgical Management
747
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
747
Drugs for Treatment of Ulcerative Colitis in IBD
553
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
553
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
950
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
950
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
583
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
583


